Tribhuvan University Teaching Hospital, Kathmandu, Nepal
Kathmandu, Nepal
NCT Number: NCT07130422
The burden of coronary artery disease (CAD) is increasing in the Nepalese population. Coronary artery bypass grafting (CABG) remains one of the most frequently performed surgical interventions for the management of advanced CAD. Despite this, there is a paucity of data regarding the incidence and determinants of surgical site infections (SSIs) following CABG in the Nepalese context. This study aimed to determine the incidence of SSIs after CABG surgery in the Nepalese population.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Kathmandu, Nepal
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CABG surgery
Time frame: 30 days post-CABG
The study aims to assess the proportion of patients developing surgical site infections within the first 30 days after undergoing coronary artery bypass graft surgery. SSIs will be identified based on standardized diagnostic criteria, and cases will be classified according to infection depth and site. Data collection will include clinical examination findings, laboratory results, and relevant imaging, ensuring comprehensive identification and categorization of infections.
Maharajgunj Medical Campus
Other
Incidence and Risk Factors of Surgical Site Infections After Coronary Artery Bypass Grafting Surgery: A Prospective Observational Study in a Tertiary Care Center in Nepal
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07060937
Arterial Occlusive Diseases, Arteriosclerosis
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT07570420
CABG
Amman, Amman Governorate, Jordan
View Trial DetailsNCT06127147
CABG, Coronary Artery Bypass Graft
Chicago, Illinois, United States
View Trial DetailsNCT07331584
CABG
Lahore, Punjab Province, Pakistan
View Trial Details